Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Garcia Weight Loss, Aesthetics & Hormone Therapy vs YourHealthRx

vs+10.199999999999996
YourHealthRx
Graded #119

Higher grade

The verdict

YourHealthRx takes it — 69.6/100 to 59.4/100.

YourHealthRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueYourHealthRx +23
30
53
Dose & formulationYourHealthRx +23
52
75
Clinical oversightYourHealthRx +8
79
87
Labs & monitoringGarcia Weight Loss, Aesthetics & Hormone Therapy +30
97
67
FulfillmentYourHealthRx +38
56
94
Contract termsGarcia Weight Loss, Aesthetics & Hormone Therapy +22
55
33
Garcia Weight Loss, Aesthetics & Hormone Therapy · left barYourHealthRx · right bar

The numbers

MetricGarcia Weight Loss, Aesthetics & Hormone TherapyYourHealthRx
WeighScore59.4/10069.6/100
GradeCC
Scorecard rank#342#119
Semaglutide$400/mo (starting dose, compounded)$170/mo (compounded)
TirzepatideNot disclosed$210/mo (compounded)
Coverage1 stateAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes

Strengths

  • Established since 2000 with 4 Tampa Bay locations and 50,000+ patients treated
  • GLP-1 program includes full metabolic and hormone lab panel
  • Medication and supplies shipped directly to your door from partner pharmacy
  • Free 15-minute consultation; both weekly-visit (Premier) and monthly-visit (Standard) tiers
  • LegitScript transparency certification listed in footer

Where it loses points

  • Florida only — 4 locations in Tampa Bay metro area only
  • Pricing not publicly listed on website ($400/month per Facebook ad)
  • Specific GLP-1 drug (semaglutide vs tirzepatide) not disclosed on site
  • Telemedicine availability not confirmed on site despite Facebook ad claims
  • In-person visit model less convenient than fully online telehealth providers
YourHealthRx

Graded #119 · C

Strengths

  • Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
  • Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
  • Flat subscription price that doesn't change as your dose increases (no titration penalty)
  • Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
  • Transparent, education-first positioning with published medical disclaimer, privacy, and terms

Where it loses points

  • Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
  • Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard